Our Research Publications
Updated November 2023
Pagination
- Previous page
- Page 10
- Next page
Title | Authors | Year | Journal Sort ascending | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Microfluidic approach to genotyping human platelet antigens | Lim C, Manage DP, Atrazhev A, Denomme G, Backhouse CJ, Acker JP | 2012 | IET Nanobiotechnol | View Microfluidic approach to genotyping human platelet antigens | Researchers | New or improved product or process |
Microfluidic analysis of red blood cell deformability as a means to assess hemin-induced oxidative stress resulting from Plasmodium falciparum intraerythrocytic parasitism | Matthews K, Duffy SP, Myrand-Lapierre M-E, Ang RR, Li L, Scott MD, Ma H | 2017 | Integr Biol | View Microfluidic analysis of red blood cell deformability as a means to assess hemin-induced oxidative stress resulting from Plasmodium falciparum intraerythrocytic parasitism | Researchers | Basic research |
Microfluidic determination of lymphocyte vascular deformability: effects of intracellular complexity and early immune activation | Kang N, Guo Q, Islamzada E, Ma H, Scott MD | 2018 | Integr Biol | View Microfluidic determination of lymphocyte vascular deformability: effects of intracellular complexity and early immune activation | Researchers | Basic research |
Microfluidic analysis of red blood cell deformability | Guo Q, Duffy SP, Matthews K, Santoso AT, Scott MD, Ma H | 2014 | J Biomech | View Microfluidic analysis of red blood cell deformability | Researchers | Basic research |
Microfluidic deformability analysis of the red cell storage lesion | Matthews K, Myrand-Lapierre M-E, Ang RR, Duffy SP, Scott MD, Ma H | 2015 | J Biomech | View Microfluidic deformability analysis of the red cell storage lesion | Researchers | New or improved product or process |
Characterizing Frailty In Myeloproliferative Neoplasms: results from the ORCHID study | Chornenki NLJ, Siegal DM, Qamar K, Woolgar S, Rangarajan S, Karampatos S, Leong DP, Hillis CM | 2022 | Leuk Res | View Characterizing Frailty In Myeloproliferative Neoplasms: results from the ORCHID study | Researchers | Clinical research |
Mesenchymal stromal cells from patients with acute myeloid leukemia have altered capacity to expand differentiated hematopoietic progenitors | Chandran P, Le Y, Li Y, Sabloff M, Mehic J, Rosu-Myles M, Allan DS | 2015 | Leuk Res | View Mesenchymal stromal cells from patients with acute myeloid leukemia have altered capacity to expand differentiated hematopoietic progenitors | Researchers | Basic research |
Membrane Type-1 Matrix Metalloproteinase Expression in Acute Myeloid Leukemia and Its Upregulation by Tumor Necrosis Factor-? | Marquez-Curtis LA, Shirvaikar N, Turner AR, Mirza I, Surmawala A, Larratt LM, Janowska-Wieczorek A | 2012 | Cancers | View Membrane Type-1 Matrix Metalloproteinase Expression in Acute Myeloid Leukemia and Its Upregulation by Tumor Necrosis Factor-? | Researchers | Basic research |
Mechanism of hemoglobin-induced cellular injury in desiccated red blood cells | Kanias T, Acker JP | 2010 | Free Radic Biol Med | View Mechanism of hemoglobin-induced cellular injury in desiccated red blood cells | Researchers | Basic research |
MDM2 antagonist nutlin plus proteasome inhibitor velcade combination displays a synergistic anti-myeloma activity | Saha MN, Jiang H, Jayakar J, Reece D, Branch DR, Chang H | 2010 | Cancer Biol Ther | View MDM2 antagonist nutlin plus proteasome inhibitor velcade combination displays a synergistic anti-myeloma activity | Researchers | Basic research |
Risk-assessment models for VTE and bleeding in hospitalized medical patients: an overview of systematic reviews | Darzi AJ, Repp AB, Spencer FA, Morsi RZ, Charide R, Etxeandia-Ikobaltzeta I, Bauer KA, Burnett AE, Cushman M, Dentali F, Kahn SR, Rezende SM, Zakai NA, Agarwal A, Karam SG, Lotfi T, Wiercioch W, Waziry R, Iorio A, Akl EA, Schünemann HJ | 2020 | Blood Adv | View Risk-assessment models for VTE and bleeding in hospitalized medical patients: an overview of systematic reviews | Health care providers | Clinical research |
Misdiagnosis of primary immune thrombocytopenia and frequency of bleeding: lessons from the McMaster ITP Registry | Arnold DM, Nazy I, Clare R, Jaffer AM, Aubie B, Li N, Kelton JG | 2017 | Blood Adv | View Misdiagnosis of primary immune thrombocytopenia and frequency of bleeding: lessons from the McMaster ITP Registry | Health care providers | Clinical research |
Stuttering priapism in a patient with sickle cell trait treated with automated red cell exchange transfusion | Ebraheem MS, Verhovsek M | 2021 | Blood Adv | View Stuttering priapism in a patient with sickle cell trait treated with automated red cell exchange transfusion | Health care providers | Clinical research |
Blood manufacturing methods affect red blood cell product characteristics and immunomodulatory activity of red blood cell products and charactersitics of extracellular vesicles. | Almizraq RJ, Norris PJ, Inglis H, Menocha S, Wirtz MR, Juffermans N, Pandey S, Spinella PC, Acker JP, Muszynski JA | 2018 | Blood Adv | View Blood manufacturing methods affect red blood cell product characteristics and immunomodulatory activity of red blood cell products and charactersitics of extracellular vesicles. | Researchers | Basic research |
The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19 | Hoiland RL, Fergusson NA, Mitra AR, Griesdale DEG, Devine DV, Stukas S, Cooper J, Thiara S, Foster D, Chen LYC, Lee AYY, Conway EM, Wellington CL, Sekhon MS | 2020 | Blood Adv | View The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19 | Health care providers | Clinical research |
Chemokines IP-10/CXCL10 and IL-8/CXCL8 are potential novel biomarkers of warm autoimmune hemolytic anemia | Branch DR, Leger RM, Sakac d, Yi Q, Duong T, Yeung RSM, Binnington B, Bloch EM | 2022 | Blood Adv | View Chemokines IP-10/CXCL10 and IL-8/CXCL8 are potential novel biomarkers of warm autoimmune hemolytic anemia | Researchers | Basic research |
Systematic review and meta-analysis of outcomes in patients with suspected pulmonary embolism | Patel P, Patel P, Bhatt M, Braun C, Begum H, Nieuwlaat R, Khatib R, Martins CC, Zhang Y, Etxeandia-Ikobaltzeta I, Varghese J, Alturkmani H, Bahaj W, Baig M, Kehar R, Mustafa A, Ponnapureddy R, Sethi A, Thomas M, Wooldridge D, Lim W, Bates SM, Lang E, Le Gal G, Haramati LB, Kline J, Righini M, Wiercioch W, Schünemann H, Mustafa RA | 2021 | Blood Adv | View Systematic review and meta-analysis of outcomes in patients with suspected pulmonary embolism | Researchers | Clinical research |
The clinical and laboratory diagnosis of vaccine-induced immune thrombotic thrombocytopenia | Bissola AL, Daka M, Arnold DM, Smith JW, Moore JC, Clare R, Ivetic N, Kelton JG, Nazy I | 2022 | Blood Adv | View The clinical and laboratory diagnosis of vaccine-induced immune thrombotic thrombocytopenia | Researchers | Clinical research |
Platelet autoantibodies in the bone marrow of patients with immune thrombocytopenia | Shrestha S, Nazy I, Smith JW, Kelton JG, Arnold DM | 2020 | Blood Adv | View Platelet autoantibodies in the bone marrow of patients with immune thrombocytopenia | Health care providers | Clinical research |
American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease | Liem RI, Lanzkron S, T DC, DeCastro L, Desai AA, Ataga KI, Cohen RT, Haynes J, Osunkwo I, Lebensburger JD, Lash JP, Wun T, Verhovsek M, Ontala E, Blaylark R, Alahdab F, Katabi A, Mustafa RA | 2019 | Blood Adv | View American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease | Health care providers | Benchmarking and standard setting |
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia. | Cuker A AG, Chong BH, Cines DB, Greinacher A, Gruel Y, Linkins LA, Rodner SB, Selleng S, Warkentin TE, Wex A, Mustafa RA, Morgan RL, Santesso N | 2018 | Blood Adv | View American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia. | Health care providers | Benchmarking and standard setting |
Management of heparin-induced thrombocytopenia: systematic reviews and meta-analyses | Morgan RL, Ashoorion V, Cuker A, Begum H, Ross S, Martinez N, Chong BH, Linkins LA, Warkentin TE, Wiercioch W, Nieuwlaat R, Schünemann H, Santesso N | 2020 | Blood Adv | View Management of heparin-induced thrombocytopenia: systematic reviews and meta-analyses | Researchers | Clinical research |
A systematic review of the association between anti-?-2 glycoprotein I antibodies and APS manifestations | Jiang D, Lim W, Crowther M, Garcia D | 2021 | Blood Adv | View A systematic review of the association between anti-?-2 glycoprotein I antibodies and APS manifestations | Researchers | Clinical research |
Genome-wide association study of platelet factor 4/heparin antibodies in heparin-induced thrombocytopenia | Giles JB, Steiner HE, Rollin J, Shaffer CM, Momozawa Y, Mushiroda T, Inai C, Selleng K, Thiele T, Pouplard C, Heddle NM, Kubo M, Miller EC, Martinez KL, Phillips EJ, Warkentin TE, Gruel Y, Greinacher A, Roden DM, Karnes JH | 2022 | Blood Adv | View Genome-wide association study of platelet factor 4/heparin antibodies in heparin-induced thrombocytopenia | Researchers | Basic research |
American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19 | Cuker A, Tseng EK, Nieuwlaat R, Angchaisuksiri P, Blair C, Dane K, Davila J, DeSancho MT, Diuguid D, Griffin DO, Kahn SR, Klok FA, Lee AI, Neumann I, Pai A, Pai M, Righini M, Sanfilippo KM, Siegal D, Skara M, Touri K, E AA, Bou Akl I, Boulos M, Brignardello-Petersen R, Charide R, Chan M, Dearness K, Darzi AJ, Kolb P, Colunga-Lozano LE, Mansour R, Morgano GP, Morsi RZ, Noori A, Piggott T, Qiu Y, Roldan Y, Schünemann F, Stevens A, Solo K, Ventresca M, Wiercioch W, Mustafa RA, Schünemann HJ | 2021 | Blood Adv | View American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19 | Health care providers | Benchmarking and standard setting |
A user guide to the American Society of Hematology clinical practice guidelines | Izcovich A, Cuker A, Kunkle R, Neumann I, Panepinto J, Pai M, Seftel M, Cheung MC, Lottenberg R, Byrne M, Plovnick R, Terrell D, Holter-Chakrabarty JL, Djulbegovic B, Hicks LK, Wiercioch W, Nieuwlaat R, Schünemann HJ | 2020 | Blood Adv | View A user guide to the American Society of Hematology clinical practice guidelines | Health care providers | Benchmarking and standard setting |
Mature murine megakaryocytes present antigen-MHC class I molecules to T cells and transfer them to platelets | Zufferey A, Speck ER, Machlus KR, Aslam R, Guo L, McVey MJ, Kim M, Kapur R, Boilard E, Italiano JE, Jr., Semple JW | 2017 | Blood Adv | View Mature murine megakaryocytes present antigen-MHC class I molecules to T cells and transfer them to platelets | Researchers | Basic research |
Characteristics of VITT antibodies in patients vaccinated with Ad26.COV2.S | Huynh A, Arnold DM, Michael JV, Clare R, Smith JW, Daka M, Ianosi-Irimie M, McKenzie SE, Kelton JG, Nazy I | 2023 | Blood Adv | View Characteristics of VITT antibodies in patients vaccinated with Ad26.COV2.S | Researchers | Clinical research |
Donor-recipient sex is associated with transfusion-related outcomes in critically ill patients | Alshalani A, Uhel F, Cremer OL, Schultz MJ, de Vooght KMK, van Bruggen R, Acker JP, Juffermans NP, on behalf of the MARS Consortium | 2022 | Blood Adv | View Donor-recipient sex is associated with transfusion-related outcomes in critically ill patients | Researchers | Clinical research |
Donor-recipient sex is associated with transfusion-related outcomes in critically ill patients | Alshalani A, Uhel F, Cremer OL, Schultz MJ, de Vooght KMK, van Bruggen R, Acker JP, Juffermans NP | 2022 | Blood Adv | View Donor-recipient sex is associated with transfusion-related outcomes in critically ill patients | Researchers | Clinical research |
SARS-CoV-2 spike-dependent platelet activation in COVID-19 vaccine-induced thrombocytopenia | Appelbaum J, Arnold DM, Kelton JG, Gernsheimer T, Jevtic SD, Ivetic N, Smith JW, Nazy I | 2022 | Blood Adv | View SARS-CoV-2 spike-dependent platelet activation in COVID-19 vaccine-induced thrombocytopenia | Researchers | Basic research |
Fetal/neonatal alloimmune thrombocytopenia: a systematic review of impact of HLA-DRB3*01:01 on fetal/neonatal outcome | Kjeldsen-Kragh J, Fergusson DA, Kjaer M, Lieberman L, Greinacher A, Murphy MF, Bussel J, Bakchoul T, Corke S, Bertrand G, Oepkes D, Baker JM, Hume H, Massey E, Kaplan C, Arnold DM, Baidya S, Ryan G, Savoia HF, Landry D, Shehata N | 2020 | Blood Adv | View Fetal/neonatal alloimmune thrombocytopenia: a systematic review of impact of HLA-DRB3*01:01 on fetal/neonatal outcome | Health care providers | Clinical research |
Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia | Kaur MN, Arnold DM, Heddle NM, Cook RJ, Hsia C, Blostein M, Jamula E, Sholzberg M, Lin Y, Kassis J, Larratt L, Tinmouth A, Carruthers J, Li N, Liu Y, Xie F | 2022 | Blood Adv | View Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia | Health care providers | Clinical research |
N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice | Chen J, Reheman A, Gushiken FC, Nolasco L, Fu X, Moake JL, Ni H, Lopez JA | 2011 | J Clin Invest | View N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice | Researchers | Basic research |
Maternal anti-platelet beta-3 integrins impair angiogenesis and cause intracranial hemorrhage | Yougbaré I, Lang S, Yang H, Chen P, Zhao X, Tai W-S, Zdravic D, Vadasz B, Li C, Piran S, Marshall A, Zhu G, Tiller H, Killie MK, Boyd S, Leong-Poi H, Wen X-Y, Skogen B, Adamson SL, Freedman J, Ni H | 2015 | J Clin Invest | View Maternal anti-platelet beta-3 integrins impair angiogenesis and cause intracranial hemorrhage | Researchers | Basic research |
The maternal immune response to fetal platelet GPIb? causes frequent miscarriage in mice that can be prevented by intravenous IgG and anti-FcRn therapies | Li C, Piran S, Chen P, Lang S, Zarpellon A, Jin JW, Zhu G, Reheman A, van der Wal DE, Simpson EK, Ni R, Gross PL, Ware J, Ruggeri ZM, Freedman J, Ni H | 2011 | J Clin Invest | View The maternal immune response to fetal platelet GPIb? causes frequent miscarriage in mice that can be prevented by intravenous IgG and anti-FcRn therapies | Researchers | Basic research |
Plasma fibronectin supports hemostasis and regulates thrombosis | Wang Y, Reheman A, Spring CM, Kalantari J, Marshall AH, Wolberg AS, Gross PL, Weitz JI, Rand ML, Mosher DF, Freedman J, Ni H | 2014 | J Clin Invest | View Plasma fibronectin supports hemostasis and regulates thrombosis | Researchers | Basic research |
Management of immune-mediated thrombocytopenia | Arnold DM, Nazi I, Smith JW, Warkentin TE | 2016 | Rossi's Principles of Transfusion Medicine | View Management of immune-mediated thrombocytopenia | Health care providers | Clinical research |
Plasma and cryoprecipitate for transfusion | Stanworth SJ, Tinmouth AT | 2016 | Rossi's Principles of Transfusion Medicine | View Plasma and cryoprecipitate for transfusion | Researchers | Basic research |
Bacterial contamination of blood components | Bloch EM, Benjamin RJ, Ramirez-Arcos S | 2022 | Rossi's Principles of Transfusion Medicine | View Bacterial contamination of blood components | Health care providers | Benchmarking and standard setting |
Management of immune‐mediated thrombocytopenia | Gabe C, Arnold D, Smith J, T W | 2022 | Rossi's Principles of Transfusion Medicine | View Management of immune‐mediated thrombocytopenia | Health care providers | Benchmarking and standard setting |
Low-intensity pulsed ultrasound-mediated stimulation of hematopoietic stem/progenitor cell viability, proliferation and differentiation in vitro | Xu P, Gul-Uludag H, Ang WT, Yang X, Huang M, Marquez-Curtis L, McGann L, Janowska-Wieczorek A, Xing J, Swanson E, Chen J | 2012 | Biotechnol Lett | View Low-intensity pulsed ultrasound-mediated stimulation of hematopoietic stem/progenitor cell viability, proliferation and differentiation in vitro | Researchers | Basic research |
A multisite study of pertussis vaccine effectiveness by time since last vaccine dose from three Canadian provinces: A Canadian Immunization Research Network study | Savage RD, Bell CA, Righolt CH, Wilkinson K, Schwartz KL, Chen C, Bolotin S, Deeks SL, Drews SJ, Jamieson FB, Johnson C, Kwong JC, Mahmud SM, Russell ML, Simmonds KA, Svenson LW, Crowcroft NS | 2021 | Vaccine | View A multisite study of pertussis vaccine effectiveness by time since last vaccine dose from three Canadian provinces: A Canadian Immunization Research Network study | Researchers | Clinical research |
Low pertussis toxin antibody levels in two regional cohorts of Canadian pregnant women | Bigham M, Konrad S, Van Buynder P, Van Buynder J, Isaac-Renton J, ElSherif M, Halperin SA | 2014 | Vaccine | View Low pertussis toxin antibody levels in two regional cohorts of Canadian pregnant women | Health care providers | Clinical research |
Vaccine-induced immune thrombotic thrombocytopenia after COVID-19 vaccination: Description of a series of 39 cases in Brazil | Mouta Nunes de Oliveira P, Mendes-de-Almeida DP, Bertollo Gomes Porto V, Crespo Cordeiro C, Vitiello Teixeira G, Saraiva Pedro R, Roberto Gomes Takey P, Kegele Lignani L, Reis Xavier J, Cardoso Doria da Gama V, Amorim Filho L, Emoingt Furtado B, Santa Maria A, Dahrug Barros T, Neves Waite Freitas L, Dos Santos Pereira T, Lima Abreu D, Bernardes Ramos M, Gabe C, Arnold D, William Smith J, Nazy I, Lourdes de Sousa Maia M | 2022 | Vaccine | View Vaccine-induced immune thrombotic thrombocytopenia after COVID-19 vaccination: Description of a series of 39 cases in Brazil | Health care providers | Clinical research |
Pertussis vaccine effectiveness in a frequency matched population-based case-control Canadian Immunization Research Network study in Ontario, Canada 2009–2015 | Crowcroft NS, Schwartz KL, Chen C, Johnson C, Li Y, Marchand-Austin A, Bolotin S, Jamieson FB, Drews SJ, Russell ML, Svenson LW, Simmonds K, Mahmud SM, Kwong JC | 2019 | Vaccine | View Pertussis vaccine effectiveness in a frequency matched population-based case-control Canadian Immunization Research Network study in Ontario, Canada 2009–2015 | Researchers | Clinical research |
Acellular pertussis vaccine effectiveness and waning immunity in Alberta, Canada: 2010–2015, a Canadian Immunization Research Network (CIRN) study | Bell CA, Russell ML, Drews SJ, Simmonds KA, Svenson LW, Schwartz KL, Kwong JC, Mahmud SM, Crowcroft NS | 2019 | Vaccine | View Acellular pertussis vaccine effectiveness and waning immunity in Alberta, Canada: 2010–2015, a Canadian Immunization Research Network (CIRN) study | Health care providers | Clinical research |
Low levels of interleukin-10 in patients with transfusion-related acute lung injury | Kapur R, Kim M, Rebetz J, Rondina MT, Porcelijn L, Semple JW | 2017 | Ann Transl Med | View Low levels of interleukin-10 in patients with transfusion-related acute lung injury | Researchers | Clinical research |
Long-term graft function following autologous hematopoietic cell transplantation and the impact of preemptive plerixafor in predicted poor mobilizers | Visram A, Bredeson C, Allan D, Sabloff M, Huebsch L, Tay J, Kekre N, McDiarmid S, Mallick R, Tinmouth A, Martin L, Hamelin L, Maze D | 2018 | Blood Cancer J | View Long-term graft function following autologous hematopoietic cell transplantation and the impact of preemptive plerixafor in predicted poor mobilizers | Health care providers | Clinical research |
Liposomes composed of unsaturated lipids for membrane modification of human erythrocytes | Stoll C, Holovati JL, Acker JP, Wolkers WF | 2011 | Mol Membr Biol | View Liposomes composed of unsaturated lipids for membrane modification of human erythrocytes | Researchers | Basic research |